For an upcoming article, we are looking for stories about what happens to a long-term relationship when one partner decides ...

In this interview, Yehuda Handelsman, MD, highlights key updates to the Diabetes, Cardiorenal, and Metabolic (DCRM) guidelines in DCRM 2.0, shaped by global collaboration and recent clinical insights.

Weight loss drugs Bariatric surgery (weight loss surgery) Why is it so hard to lose weight and keep it off? Obesity is a ...

Novo Nordisk ( NYSE:NVO) has secured approval from the European Medicines Agency (EMA) for a kidney disease-related label ...

MILLIONAIRE ‘biohacker’ Bryan Johnson has embarked on several wacky schemes in a bid to turn back the clock. They range from infusing his son’s plasma into his blood to injecting a ...

Wellness expert Ateh Jewel says taking weight loss drug Ozempic has been 'illuminating' – here's what she wants others to ...

GLP-1 drugs are remarkably effective at addressing obesity, cardiovascular, and metabolic conditions, but investigators ...

Undiagnosed or untreated EPI could result in muscle loss since the patient isn’t absorbing the necessary nutrients.

The FDA declared the tirzepatide shortage over in October 2023, but a lawsuit by Outsourcing Facilities Association, a trade ...

The expansive roles of gut peptides suggest they may be leveraged in a variety of applied research domains. Their modular structure, receptor-specificity, and potential bioactivity make them ...

The following is a summary of “Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity,” published in the ...

The reach of GLP-1 drugs has widened in ways its inventors likely never imagined. Clinical trials are underway testing GLP-1 drugs to treat Alzheimer's, Parkinson's, and even drug addiction, plus ...